Correlation Between Rezolute and CytomX Therapeutics
Can any of the company-specific risk be diversified away by investing in both Rezolute and CytomX Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rezolute and CytomX Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rezolute and CytomX Therapeutics, you can compare the effects of market volatilities on Rezolute and CytomX Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rezolute with a short position of CytomX Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rezolute and CytomX Therapeutics.
Diversification Opportunities for Rezolute and CytomX Therapeutics
-0.36 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Rezolute and CytomX is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Rezolute and CytomX Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CytomX Therapeutics and Rezolute is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rezolute are associated (or correlated) with CytomX Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CytomX Therapeutics has no effect on the direction of Rezolute i.e., Rezolute and CytomX Therapeutics go up and down completely randomly.
Pair Corralation between Rezolute and CytomX Therapeutics
Given the investment horizon of 90 days Rezolute is expected to under-perform the CytomX Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Rezolute is 1.28 times less risky than CytomX Therapeutics. The stock trades about -0.1 of its potential returns per unit of risk. The CytomX Therapeutics is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 100.00 in CytomX Therapeutics on September 1, 2024 and sell it today you would earn a total of 6.00 from holding CytomX Therapeutics or generate 6.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Rezolute vs. CytomX Therapeutics
Performance |
| Timeline |
| Rezolute |
| CytomX Therapeutics |
Rezolute and CytomX Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Rezolute and CytomX Therapeutics
The main advantage of trading using opposite Rezolute and CytomX Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rezolute position performs unexpectedly, CytomX Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CytomX Therapeutics will offset losses from the drop in CytomX Therapeutics' long position.The idea behind Rezolute and CytomX Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| CytomX Therapeutics vs. Spero Therapeutics | CytomX Therapeutics vs. Instil Bio | CytomX Therapeutics vs. NextCure | CytomX Therapeutics vs. Assembly Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |